CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹306 Cr | ₹331 Cr | ₹268 Cr | ₹208 Cr | ₹143 Cr |
What is the latest Total Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹306 Cr |
Mar2024 | ₹331 Cr |
Mar2023 | ₹268 Cr |
Mar2022 | ₹208 Cr |
Mar2021 | ₹143 Cr |
How is Total Current Liabilities of CAPLIN POINT LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹306 Cr | -7.51 | |
Mar2024 | ₹331 Cr | 23.45 | |
Mar2023 | ₹268 Cr | 29.04 | |
Mar2022 | ₹208 Cr | 45.38 | |
Mar2021 | ₹143 Cr | - |
Compare Total Current Liabilities of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹17,819.0 Cr | 3.2% | 10.9% | 15.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | 3.2% |
10.9% |
15.7% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses